on Medicure, Inc. (NASDAQ:MCUJF)
Medicure Reaches Settlement in Product Development and Supply Contract
Medicure Inc., a pharmaceutical company based in Winnipeg, Manitoba, has successfully reached a settlement regarding a product development and supply contract. This settlement involves its subsidiaries, Medicure International Inc. and Medicure Pharma Inc., alongside a third party whose identity remains undisclosed.
As part of the settlement agreement, Medicure received a payment of €1.5 million. While the terms of the settlement have not been fully disclosed, the company has emphasized its commitment to resolving contractual matters efficiently.
Medicure continues to focus on developing and commercializing healthcare products in the United States, notably AGGRASTAT® and ZYPITAMAG®, through its U.S. subsidiary, Medicure Pharma Inc.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Medicure, Inc. news